The Latin American Examiner
SEE OTHER BRANDS

The top news stories from Latin America

The Latin American Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Latin American Examiner.

Press releases published on August 14, 2025

Nasus Pharma Announces Closing of Initial Public Offering

Nasus Pharma Announces Closing of Initial Public Offering

TEL AVIV, Israel, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions …

Vaxart to Host Virtual Stockholder Fireside Chat on Wednesday, August 20 to Discuss Reverse Stock Split Proposal

Vaxart to Host Virtual Stockholder Fireside Chat on Wednesday, August 20 to Discuss Reverse Stock Split Proposal

- ISS and Glass Lewis, leading independent proxy advisory firms, support reverse stock split proposal - - Webcast to begin at 4:30 p.m. ET / 1:30 p.m. PT - SOUTH SAN FRANCISCO, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a …

Red Cat Reports Financial Results for Second Quarter 2025 and Provides Corporate Update

Red Cat Reports Financial Results for Second Quarter 2025 and Provides Corporate Update

SAN JUAN, Puerto Rico, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (Nasdaq: RCAT) ("Red Cat" or the "Company"), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, reports …

Century Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Century Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Patient dosing ongoing in CALiPSO-1 trial; on track to report clinical data for CNTY-101 in patients with B-cell-mediated autoimmune diseases by year-end 2025 CNTY-308, a CAR-iT cell therapy functionally comparable to primary T cells, now in IND-enabling …

MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities

MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities

Newly-appointed President and CEO, Eric Risser, outlines strategic priorities for 2025 and 2026 Received $70 million upfront cash payment from Sagard Healthcare Partners under a royalty purchase agreement for ZYNYZ® Cash, cash equivalents and marketable …

Ligand Announces Closing of Convertible Senior Notes Offering

Ligand Announces Closing of Convertible Senior Notes Offering

JUPITER, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) (“Ligand”) announced today that it completed its previously announced offering (the “offering”) of 0.75% convertible senior notes due 2030 (the “notes”). …

Oxbridge Highlights Growth in Tokenized Reinsurance, Strategic Partnerships, and Reports Q2 2025 Results

Oxbridge Highlights Growth in Tokenized Reinsurance, Strategic Partnerships, and Reports Q2 2025 Results

GRAND CAYMAN, Cayman Islands, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Oxbridge Re Holdings Limited (NASDAQ: OXBR), (the “Company”), a leader in digitizing reinsurance securities as tokenized real-world assets (RWAs), together with its subsidiary SurancePlus, …

Surge Copper Provides Corporate and Operational Update

Surge Copper Provides Corporate and Operational Update

Vancouver, British Columbia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) (“Surge” or the “Company”) is pleased to provide a corporate update covering ongoing field activities, upcoming investor events, …

LYNO AI Early Bird Presale Exceeds 265K Tokens Sold as Price Increase Approaches

LYNO AI Early Bird Presale Exceeds 265K Tokens Sold as Price Increase Approaches

ROAD TOWN, British Virgin Islands, Aug. 14, 2025 (GLOBE NEWSWIRE) -- LYNO AI today announced that its Early Bird presale phase has achieved strong momentum, with over 265,000 tokens sold in a short span of time. Currently priced at $0.050 per token, this …

Lancaster Resources Commences Field Work for Maiden NI 43-101 Technical Report at Lake Cargelligo Gold Project, Australia

Lancaster Resources Commences Field Work for Maiden NI 43-101 Technical Report at Lake Cargelligo Gold Project, Australia

VANCOUVER, British Columbia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Lancaster Resources Inc. (CSE:LCR | OTCQ:LANRF | FRA:6UF0) (the “Company” or “Lancaster”) is pleased to announce the start of desk and field work at its 100%-owned Lake Cargelligo Gold Project …

Confidence Soars as LYNO AI Presale Approaches Quarter-Million Token Milestone

Confidence Soars as LYNO AI Presale Approaches Quarter-Million Token Milestone

ROAD TOWN, British Virgin Islands, Aug. 14, 2025 (GLOBE NEWSWIRE) -- LYNO AI is hitting the headlines as its presale nears a major milestone, with a total of more than 269,879 tokens already sold during the Early Bird stage alone. The token price is now at …

Bitget’s July Report Shows $461M Net Inflows and 100K New Copy Trading Users

Bitget’s July Report Shows $461M Net Inflows and 100K New Copy Trading Users

VICTORIA, Seychelles, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Bitget, the world's leading cryptocurrency exchange and Web3 company, ended July with another month of strong growth and global brand expansion. The platform maintained its CoinGecko Spot ranking as …

Jet.AI Inc. Announces Strategic Capital Contribution to AIIA Sponsor Ltd., the Sponsor of a SPAC Organized to Pursue AI, Machine Learning, and Data Center Operations

Jet.AI Inc. Announces Strategic Capital Contribution to AIIA Sponsor Ltd., the Sponsor of a SPAC Organized to Pursue AI, Machine Learning, and Data Center Operations

LAS VEGAS, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Jet.AI Inc. ( “Jet.AI” or the “Company”) (Nasdaq: JTAI), a provider of high-performance GPU infrastructure and AI cloud services, today announced it has made a capital contribution to AIIA Sponsor Ltd. (“Sponsor …

GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Live video webcast on Wednesday, August 20th at 2:20 PM ET LA JOLLA, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell …

Credicorp Ltd.: Credicorp Ltd. Updates on Tax Dispute with SUNAT

Credicorp Ltd.: Credicorp Ltd. Updates on Tax Dispute with SUNAT

Lima, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Lima, Peru – August 14, 2025 – Credicorp Ltd. (“Credicorp” or “the Company”) (NYSE: BAP | BVL: BAP), the leading financial services holding company in Peru with a presence in Chile, Colombia, Bolivia, and Panama, …

GoldHaven Resources Identifies Critical, Base and Precious Metals at Magno Project: Indium, Tin, Zinc, Silver & Gold Highlight Exploration Potential

GoldHaven Resources Identifies Critical, Base and Precious Metals at Magno Project: Indium, Tin, Zinc, Silver & Gold Highlight Exploration Potential

VANCOUVER, British Columbia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- GoldHaven Resources Corp. ("GoldHaven" or the "Company") (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) is pleased to provide an update following further studies and interpretation completed on its Magno …

AIM ImmunoTech to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

AIM ImmunoTech to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

OCALA, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that it will present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech being held virtually August 19- …

Clene Reports Second Quarter 2025 Financial Results and Recent Operating Highlights

Clene Reports Second Quarter 2025 Financial Results and Recent Operating Highlights

Following constructive FDA feedback on its proposed statistical analysis plan, Clene plans to analyze the neurofilament light data from its large NIH-sponsored Early Access Protocol early in the fourth quarter of 2025 A second Type C meeting has been …

Enlivex to Present 3-Month Topline Data from Phase IIa Moderate/Severe Knee Osteoarthritis Trial on August 18 Webinar

Enlivex to Present 3-Month Topline Data from Phase IIa Moderate/Severe Knee Osteoarthritis Trial on August 18 Webinar

Webinar to Review Results from Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Allocetra™ in Patients with Moderate to Severe Knee Osteoarthritis Nes-Ziona, Israel, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. ( …

Outlook Therapeutics Reports Financial Results for Third Quarter Fiscal Year 2025 and Provides Corporate Update

Outlook Therapeutics Reports Financial Results for Third Quarter Fiscal Year 2025 and Provides Corporate Update

First commercial sales of LYTENAVA™ (bevacizumab gamma) achieved in Europe ONS-5010/LYTENAVA™ (bevacizumab-vikg) Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025, in the United States ISELIN, N.J., Aug. 14, 2025 (GLOBE NEWSWIRE) -- …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions